Insiders Trades
Bavarian Nordic A/S Stock: price and insider trades · Denmark
No insider purchase over the last 90 days. The latest was filed 04 Sept 2023.
Bavarian Nordic A/S: what insiders have been doing
Bavarian Nordic A/S, classified in the Healthcare & Pharma sector, is a listed company based in Hellerup, Denmark, founded in 1992. Its latest reported headcount is 1,653 employees (2024). Its insiders report their share dealings to Finanstilsynet DK. 3 insiders have disclosed 4 filings since 18 October 2025.
All open-market trades in the period are sales: 1 sale worth €2.6M, by 1 insider, with no purchase on record. One trade stands out by size: a sale of €2.6M, disclosed on 25 August 2026, or 0.12% of market capitalisation.
Compared with its exchange (74 companies, median 4 filings), a count of 4 filings is typical. Over the whole record (from 2005), the tally stands at 2 purchases and 5 sales.
Half of the filings or more reach the Finanstilsynet DK feed on the day of the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. Every figure here comes from the filings published by Finanstilsynet DK and describes the past, not future prices; it is not investment advice.
Insider Decl.
84
Thresholds
n/a
Buy Volume
€167,333
2 ops. · all time
Sell Volume
€6M
5 ops. · all time
Who traded when
BuySaleAnonymous (PDMR)1 sale
Analyst consensus: bullish or bearish?
Analysts rate Bavarian Nordic A/S Strong Buy (bullish), based on 4 analysts. Average price target: DKK 276.25.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 1,244 of 24,148 companies
78.6
score / 100
Value77
Quality80
FCF yld7.6%
Earn yld7.7%
EV/EBITDA7.2x
ROE12%
Gross mgn49%
Net mgn22%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
DKK 239.00
Analyst consensus
4 analystsStrong buy
DKK 265.00Target DKK 276.25(+16%)DKK 290.00
Income statement
RevenueDKK 6.2B
Gross profitDKK 3B49% margin
EBITDADKK 2.5B40% margin
Net incomeDKK 1.4B24.3% margin
Valuation
PER (trailing)12.3x
PER (forward)22.0x
P/Book1.4x
Beta0.98
Balance sheet & cash
Market capDKK 17.9B
Total debtDKK 130.9M
Free Cash FlowDKK 1.4B
Debt / Equity1%
Profitability & ownership
ROE12.2%
ROA5.0%
% insiders0.0%
% institutions35.9%
Last declaration on 4 September 2026
Declarations84 total
28,590 shares@ DKK 190.110.033% mcap22.1% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1461957
90,000 shares@ DKK 212.42140.12% mcap77.9% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1460160
771 shares@ DKK 188.300.0010% mcap0.2% of flowShareOutside a trading venueISIN DK0015998017DK:1442171
10,642 shares@ DKK 177.650.013% mcap2.1% of flowShareOutside a trading venueISIN DK0015998017DK:1426172
983 shares@ DKK 152.580.0011% mcap0.2% of flowShareOutside a trading venueISIN DK0015998017DK:1362382
12,543 shares@ DKK 108.710.0097% mcap1.5% of flowShareOutside a trading venueISIN DK0015998017DK:1347025
54,669 shares0ShareOutside a trading venueISIN DK0015998017DK:1333439
2,596 shares@ DKK 146.600.0027% mcap0.4% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1330866
98,855 shares@ DKK 243.80270.17% mcap27.2% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1315150
98,855 shares@ DKK 146.600.10% mcap16.4% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1314963
200 shares@ DKK 275.970.0004% mcap0.1% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1312612
2,966 shares0ShareOutside a trading venueISIN DK0015998017DK:1294225
823 shares@ DKK 273.250.0016% mcap0.3% of flowShareOutside a trading venueISIN DK0015998017DK:1289504
8,258 shares@ DKK 148.170.0087% mcap1.4% of flowShareOutside a trading venueISIN DK0015998017DK:1280657
26,736 shares@ DKK 108.880.021% mcap3.3% of flowShareOutside a trading venueISIN DK0015998017DK:1279419
57,836 shares0ShareOutside a trading venueISIN DK0015998017DK:1264735
67,788 shares@ DKK 142.000.069% mcap10.9% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1262459
4,800 shares@ DKK 154.690.0053% mcap0.8% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1246283
Canonical exit: 3 Dec 2023 (T+90)
3,375 shares@ DKK 149.560.0036% mcap0.6% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1246015
Canonical exit: 30 Nov 2023 (T+90)
1,185 shares@ DKK 189.740.0016% mcap0.3% of flowShareOutside a trading venueISIN DK0015998017DK:1233231
9,000 shares@ DKK 155.800.010% mcap1.6% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1229638
12,976 shares@ DKK 99.530.0092% mcap1.5% of flowShareOutside a trading venueISIN DK0015998017DK:1224301
2,313 shares0ShareOutside a trading venueISIN DK0015998017DK:1222422
14,000 shares@ DKK 155.800.016% mcap2.5% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1213965
10,642 shares@ DKK 151.550.012% mcap1.8% of flowShareOutside a trading venueISIN DK0015998017DK:1210681
25 of 84 declarations
About Bavarian Nordic A/S
Bavarian Nordic A/S is a Danish biopharmaceutical company focused on the development of vaccines and treatments for infectious diseases and cancer. It emphasizes innovation in therapeutic and preventive vaccines.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
